SMARCA2

Notes

original target text: SMARCA2 degrader

SMARCA2 (also called BRM) is one of two alternative catalytic ATPase subunits — the other being its close relative SMARCA4 (BRG1) — that can power the SWI/SNF (BAF) chromatin-remodeling complex. This complex uses energy from ATP to reposition nucleosomes, the spool-like structures around which DNA is wound, thereby controlling which genes are accessible for transcription. In many cancers, tumor cells lose functional SMARCA4 through mutation, and in that setting SMARCA2 becomes the sole remaining ATPase capable of sustaining SWI/SNF activity, upon which the cancer cell survival becomes disproportionately dependent. This creates a therapeutic opportunity: selectively eliminating SMARCA2 in SMARCA4-deficient tumor cells can be lethal to the cancer while largely sparing normal cells, which retain a functioning SMARCA4 copy to carry out the same chromatin-remodeling role. Because SMARCA2 and SMARCA4 are highly similar in structure, achieving selective inhibition or removal of one without affecting the other is technically demanding. Protein degraders, which mark the target protein for cellular disposal rather than merely blocking its enzymatic pocket, are one strategy being explored to reach this level of selectivity. This mechanism is primarily relevant to solid tumors defined by loss of SMARCA4 function.